Tine Rask Licht
Tine Rask Licht heads the The National Food Institute research group on Intestinal Microbial Ecology.
The focus of our research is on effects of diet on composition, activity and genetic exchange in the gut microbiota, as well as on effects of the gut environment on resistance to pathogenic infections. Additionally, we adress the impact of gut microbes on maturation and maintenance of the host immune system. We look at effects of whole food items as well as of prebiotic carbohydrates and probiotic bacteria.
Dr Maria Kyrgiou
Dr Maria Kyrgiou is a Clinical Senior Lecturer at Imperial College London and Consultant Gynaecologist and Gynaecologic Oncologist at the West London Gynaecological Cancer Centre, Imperial Healthcare NHS Trust.
The primary focus of her research is traslational research in gynaecological cancers, in particular cervical and endometrial cancer. She has led research into the impact of treatment for cervical pre-invasive and early invasive cervical disease on reproductive outcomes and the clinical use of HPV biomarkers in personalising the management of women with abnormal findings at screening. She has an interest in the role of obesity and metabolic disorders in endometrial tumorigenesis.
Katri Korpela
Aletta Kraneveld
In 2016 Aletta Kraneveld (MSc Pharmacy & pharmacologist) was appointed as full professor Interdisciplinary Translational Pharmacology at the Faculty of Science and the Faculty of Veterinary Medicine of the Utrecht University. She has published >120 papers (H-index: 42). Besides science, she is/has been an active member of several boards of (inter)national scientific and societal organizations (Dutch Society of Pharmacology, EPHAR, IUPHAR, Netherlands Federation of Innovative Drug research; Diversity committee UU; Food Lives-NL).
Kraneveld’s current research interests involve targeting the interaction between innate and adaptive immunity as well as host-microbiome interactions in chronic (inflammatory) diseases with pharmaceutical as well as nutritional interventions. The Kraneveld group is focusing research to in depth study the role of the gut-immune-brain-axis in neurodevelopmental and neurodegenerative disorders. Results will further enhance the knowledge of the interaction of microbiome with the immune and nervous systems in chronic conditions in the gut and CNS. Aletta Kraneveld has set up a program that is a (inter)national neuro-immune platform where academia, patient organisations and industry meet for research on the gut-immune-brain axis as target for medicine and medical food concepts.